Project Team Leader, Biology

We are seeking a Project Team Leader to drive oncology drug discovery programs from target validation through IND. This is a pivotal role that sits between hands‑on execution and research leadership: you will translate strategic direction into actionable program plans, provide scientific leadership to a small team of scientists, and serve as the biology point person on cross‑functional project teams.

Our work sits at the intersection of targeted protein degradation and antibody-based delivery, so demonstrated experience across both degrader and ADC modalities is central to this role. You will be the connective tissue between day‑to‑day execution and research strategy — setting scientific direction, unblocking the team, and keeping programs moving toward the clinic.

• Lead the biology strategy and execution for one or more oncology discovery programs spanning target validation, hit-to-lead, lead optimization, and IND-enabling studies.
• Design and oversee in vitro and in vivo plans to characterize degrader (molecular glue / PROTAC) and degrader antibody conjugate candidates — including mechanism of action, ternary complex / degradation readouts, antigen selection and internalization, linker-payload and DAR considerations, PK/PD, and efficacy in relevant tumor models.
• Serve as the biology representative on cross‑functional project teams, partnering with chemistry, DMPK, toxicology, CMC, and translational functions to advance candidates toward IND.
• Translate high‑level research strategy into clear workplans, timelines, and go/no‑go criteria; anticipate risks and propose data‑driven mitigations.
• Coordinate and oversee in vivo studies end to end, including scoping, CRO selection and management, dosing design, and data integrity.
• Mentor and provide scientific guidance to junior scientists, building ownership and independent decision‑making rather than directing execution top‑down.
• Analyze, interpret, and clearly communicate data and program status to research leadership and the broader organization.
• Contribute to target evaluation, portfolio strategy, and the shaping of new program concepts.

• PhD in cancer biology, molecular/cell biology, pharmacology, biochemistry, or a related field, with 8+ years or a Master's degree with commensurate experience 12+ years and a demonstrated record of independently leading discovery programs.
• Demonstrated track record advancing oncology discovery programs toward IND.
• Program-level or hands‑on experience with targeted protein degradation — e.g., E3 ligase biology, molecular glues and/or PROTACs, ternary complex formation, degradation assays (HiBiT, immunoblot, proteomics).
• Experience with antibody-drug conjugates (ADCs) — e.g., target/antigen selection, internalization, linker-payload biology, DAR, bystander effect, and in vitro/in vivo characterization.
• Proven ability to design and interpret in vivo oncology pharmacology studies (xenograft / PDX, PK/PD, efficacy) and to manage CRO‑run studies.
• Strong record of cross‑functional collaboration across discovery and development.

• Experience at the intersection of modalities (e.g., degrader‑antibody conjugates or targeted delivery of degraders).
• Experience authoring or contributing to IND packages and interfacing with regulatory, DMPK, and toxicology functions.
• Familiarity with biomarker and translational strategy in oncology.
• Experience mentoring or leading scientists in a matrixed or flat organization spanning multiple sites and time zones.

• Strategic — sees beyond the next experiment; connects data to program decisions and portfolio direction, and helps set the scientific agenda.
• Independent & self-driven — takes ownership of programs and moves them forward without close direction; comfortable operating with autonomy across sites and time zones.
• Collaborative — builds trust across functions and sites, communicates openly, and elevates the people around them.
• A multiplier, not a micromanager — empowers junior scientists to own their studies and make (and learn from) their own decisions, while providing clear scientific guidance and support.

*…